Uptravi
Ended Awarded
- Contract number
- 36C26124N0356
- Awardee
-
Actelion Pharmaceuticals US, Inc. UEI H5BMHLMMNA28
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $14,585
Award facts
- Contract value 100% obligated
- $14,584.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Titusville, Hopewell Township, NJ 08560, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $14,584.53 firm fixed price delivery order contract to Actelion Pharmaceuticals US, Inc. for the drug UPTRAVI. The contract was awarded under Actelion Pharmaceuticals US, Inc.'s Pharmaceuticals and Drugs (FSS-61-IB) master agreement with the General Services Administration. Place of performance will be Actelion Pharmaceuticals US, Inc.'s Division location in Titusville, New Jersey. The contract period of performance spans from December 28, 2023 through February 28, 2024. No subcontractors or set aside designations were identified. This order supports the VA's mission to provide healthcare services to veterans through its Veterans Health Administration integrated network.
Quick answers
Who was awarded contract 36C26124N0356?
36C26124N0356 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on December 28, 2023.
How much is contract 36C26124N0356 worth?
The government has obligated $14,585 on 36C26124N0356.
Is contract 36C26124N0356 an order under another contract?
Yes. 36C26124N0356 is a delivery order under 36F79719D0142, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0356 competed?
The extent of competition for 36C26124N0356 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award